soul trial oral semaglutide cardiovascular outcomes nejm 2025 results The Study SOUL trial shows oral semaglutide

This project was financially supported in part by the National Institutes of Health (NIH) grant R01AI076456 (to P.J.B), NIH grant K08DK097721 (to J.B.W.), Northwestern University Allergy Immunology Research (NUAIR) T32 (5T32AI083216-03), and internal funding from Ann and Robert H

Patients with myasthenia gravis require careful consideration when prescribing new medications, as certain drugs can exacerbate muscle weakness or precipitate myasthenic crisis

A single serious event has been reported in research: one Parkinsons patient at a high daily dose (600 mg) developed rapid heart rate and cardiomyopathy that resolved after stopping intranasal glutathione

Use in Type 2 Diabetes Management Use in Type 2 Diabetes Management Semaglutide is widely used in the management of type 2 diabetes mellitus

Finding healthy ways to manage stress supports better results

Once your evaluation is complete with our physicians or PAs, our RNs who are experienced ICU nurses start your IV infusion and monitor your symptoms during the treatment